Stock Events

Stock Events

Filana Therapeutics (SAVA) Q1 2026 Earnings

12MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.92

-0.69

-0.45

-0.22

Details

Expected EPS

-0.3

Actual EPS

-0.26

Surprise EPS

0.04

Surprise Percent

+13.33%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.26 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.